Clinical Trial Update: Efficacy and Safety of PRO-155 Versus Nevanac in Post Phacoemulsification [Phase 2]

View source ↗

Summary

Phase 2 trial comparing PRO-155 to Nevanac for efficacy and safety after cataract surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Nevanak (nevanac)
• PRO-155

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Cataract, Phacoemulsification Cataract Surgery | Phase 2 | Status: COMPLETED | Results posted: 2018-10-30